Brief: Denali Therapeutics Says Co Prices Public Offering Of 9.14 Mln Shares At $17.50 Each
Dec 10 (Reuters) - Denali Therapeutics Inc DNLI.O: DENALI THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS DENALI THERAPEUTICS INC - PRICES PUBLIC OFFERING OF 9,142,857 SHARES AT $17.50 EACH Source text: ID:nGNX3HsLpx Further company coverage: DNLI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Denali Therapeutics
See all newsDenali Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Denali Therapeutics Q2 net loss widens as AVLAYAH launch costs rise
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed
U.S. STOCKS ON THE MOVE-Sweetgreen, Dell Technologies, Peloton Interactive
U.S. STOCKS ON THE MOVE-IMAX, Novo Nordisk, PC makers